Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Erlotinib | HCID 176870 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | Erlotinib Hydrochloride | HCID 176871 | 0.02% |
Reaction Steps
Crude erlotinib free base (10 gm, HPLC purity: 98.2%; Content of N-methoxyethyl impurity: 0.24%) is dissolved in dimethylsulfoxide (50 ml) at 25-30° C., to the solution is added 15% methanolic HCl (100 ml) at 25-30° C. while the pH of the mass is adjusted to 2 and then stirred for 30-40 minutes at 25-30° C. The material is filtered, washed with a mixture of dimethyl sulfoxide (10 ml) and methanol (20 ml), and then the material is dried at 60-65° C. under vacuum for 5 hours to give 8.9 gm of pure erlotinib hydrochloride [HPLC purity: 99.92%; Content of N-methoxyethyl impurity: 0.02% (at 1.14 RRT)].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08389531B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-3d61a65de5c3458385c68fac63b89948 |
|---|
| Source note | uspto-grants-2013_03 |
|---|